185 related articles for article (PubMed ID: 19481150)
1. No differences of butyrylcholinesterase protein activity and allele frequency in Lewy body diseases.
Maetzler W; Keller S; Michelis J; Koehler N; Stransky E; Becker C; Schulte C; Melms A; Gasser T; Berg D
Neurobiol Dis; 2009 Aug; 35(2):296-301. PubMed ID: 19481150
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein ε4 modulates phenotype of butyrylcholinesterase in CSF of patients with Alzheimer's disease.
Darreh-Shori T; Siawesh M; Mousavi M; Andreasen N; Nordberg A
J Alzheimers Dis; 2012; 28(2):443-58. PubMed ID: 22012848
[TBL] [Abstract][Full Text] [Related]
3. Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism.
Darreh-Shori T; Brimijoin S; Kadir A; Almkvist O; Nordberg A
Neurobiol Dis; 2006 Nov; 24(2):326-33. PubMed ID: 16973370
[TBL] [Abstract][Full Text] [Related]
4. Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease.
Vijayaraghavan S; Darreh-Shori T; Rongve A; Berge G; Sando SB; White LR; Auestad BH; Witoelar A; Andreassen OA; Ulstein ID; Aarsland D
J Alzheimers Dis; 2016; 50(2):567-76. PubMed ID: 26757188
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
[TBL] [Abstract][Full Text] [Related]
6. Emerging hypotheses regarding the influences of butyrylcholinesterase-K variant, APOE epsilon 4, and hyperhomocysteinemia in neurodegenerative dementias.
Lane RM; He Y
Med Hypotheses; 2009 Aug; 73(2):230-50. PubMed ID: 19359103
[TBL] [Abstract][Full Text] [Related]
7. Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease.
Raygani AV; Zahrai M; Soltanzadeh A; Doosti M; Javadi E; Pourmotabbed T
Neurosci Lett; 2004 Nov; 371(2-3):142-6. PubMed ID: 15519745
[TBL] [Abstract][Full Text] [Related]
8. Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain).
Déniz-Naranjo MC; Muñoz-Fernández C; Alemany-Rodríguez MJ; del Carmen Pérez-Vieitez M; Aladro-Benito Y; Irurita-Latasa J; Sánchez-García F
Neurosci Lett; 2007 Oct; 427(1):34-8. PubMed ID: 17923322
[TBL] [Abstract][Full Text] [Related]
9. Increased serum butyrylcholinesterase activity in type IIb hyperlipidaemic patients.
Kálmán J; Juhász A; Rakonczay Z; Abrahám G; Zana M; Boda K; Farkas T; Penke B; Janka Z
Life Sci; 2004 Jul; 75(10):1195-204. PubMed ID: 15219807
[TBL] [Abstract][Full Text] [Related]
10. Homozygosity for the K variant of BCHE gene increases the risk for development of neurofibrillary pathology but not amyloid deposits at young ages.
Ghebremedhin E; Thal DR; Schultz C; Braak H; Deller T
Acta Neuropathol; 2007 Oct; 114(4):359-63. PubMed ID: 17701416
[TBL] [Abstract][Full Text] [Related]
11. The k variant of the butyrylcholinesterase gene is associated with reduced phosphorylation of tau in dementia patients.
Ballard C; Morris C; Kalaria R; McKeith I; Perry R; Perry E
Dement Geriatr Cogn Disord; 2005; 19(5-6):357-60. PubMed ID: 15802910
[TBL] [Abstract][Full Text] [Related]
12. Neprilysin activity in cerebrospinal fluid is associated with dementia and amyloid-β42 levels in Lewy body disease.
Maetzler W; Stoycheva V; Schmid B; Schulte C; Hauser AK; Brockmann K; Melms A; Gasser T; Berg D
J Alzheimers Dis; 2010; 22(3):933-8. PubMed ID: 20858953
[TBL] [Abstract][Full Text] [Related]
13. BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline.
Lane R; He Y; Morris C; Leverenz JB; Emre M; Ballard C
Mov Disord; 2009 Feb; 24(3):392-400. PubMed ID: 19006190
[TBL] [Abstract][Full Text] [Related]
14. Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease.
Darreh-Shori T; Vijayaraghavan S; Aeinehband S; Piehl F; Lindblom RP; Nilsson B; Ekdahl KN; Långström B; Almkvist O; Nordberg A
Neurobiol Aging; 2013 Nov; 34(11):2465-81. PubMed ID: 23759148
[TBL] [Abstract][Full Text] [Related]
15. Interaction between CYP19 aromatase and butyrylcholinesterase genes increases Alzheimer's disease risk.
Combarros O; Riancho JA; Infante J; Sañudo C; Llorca J; Zarrabeitia MT; Berciano J
Dement Geriatr Cogn Disord; 2005; 20(2-3):153-7. PubMed ID: 16020944
[TBL] [Abstract][Full Text] [Related]
16. No association between butyrylcholinesterase K-variant and Alzheimer disease in Chinese.
Lee DW; Liu HC; Liu TY; Chi CW; Hong CJ
Am J Med Genet; 2000 Apr; 96(2):167-9. PubMed ID: 10893490
[TBL] [Abstract][Full Text] [Related]
17. Association of variants of the -116 site of the butyrylcholinesterase BCHE gene to enzyme activity and body mass index.
Furtado-Alle L; Andrade FA; Nunes K; Mikami LR; Souza RL; Chautard-Freire-Maia EA
Chem Biol Interact; 2008 Sep; 175(1-3):115-8. PubMed ID: 18550040
[TBL] [Abstract][Full Text] [Related]
18. Effect of apolipoprotein E and butyrylcholinesterase genotypes on cognitive response to cholinesterase inhibitor treatment at different stages of Alzheimer's disease.
Patterson CE; Todd SA; Passmore AP
Pharmacogenomics J; 2011 Dec; 11(6):444-50. PubMed ID: 20644562
[TBL] [Abstract][Full Text] [Related]
19. Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition.
Peskind ER; Li G; Shofer J; Quinn JF; Kaye JA; Clark CM; Farlow MR; DeCarli C; Raskind MA; Schellenberg GD; Lee VM; Galasko DR
Arch Neurol; 2006 Jul; 63(7):936-9. PubMed ID: 16831961
[TBL] [Abstract][Full Text] [Related]
20. Influence of genetic polymorphisms in the apolipoprotein (APOE) and the butyrylcholinesterase (BCHE) gene on stress markers in older adults: a 3-year study.
Fiocco AJ; Nair NP; Schwartz G; Kin FN; Joober R; Poirier J; Lupien SJ
Neurobiol Aging; 2009 Jun; 30(6):1001-5. PubMed ID: 17996334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
